Ayumi. Yoshizaki, et.al., CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma., The American journal of pathology, 2008, 172

http://rdf.ncbi.nlm.nih.gov/pubmed/18467694

Ayumi. Yoshizaki, et.al., CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma., The American journal of pathology, 2008, 172

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• thick dermal layer_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0001245B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased IgM level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0001806B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased IgA level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0001807B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• abnormal B cell physiology_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0002459B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased anti-nuclear antigen antibody level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0004795B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased anti-double stranded DNA antibody level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0004798B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
他11件を見る
• decreased IgG1 level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008495B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased IgG2a level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008496B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased IgG2b level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008497B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased IgG3 level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008498B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased circulating tumor necrosis factor level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008554B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased circulating interferon-gamma level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008578B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased circulating interleukin-10 level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008594B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased circulating interleukin-6 level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008597B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased circulating interleukin-4 level_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008603B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• decreased physiological sensitivity to xenobiotic_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0008874B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft
• skin fibrosis_Cd19<tm1Tft>/Cd19<tm1Tft>
  http://metadb.riken.jp/0009932B6CgCd19tm1TftCd19tm1TftCd19tm1TftCd19tm1Tft